Geron Corp GERN:NASDAQ

Last Price$1.67NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+0.12(7.74%)
Bid (Size)$1.63 (31)
Ask (Size)$1.67 (29)
Day Low / High$1.54 - 1.68
Volume3.6 M
 

View Biotechnology IndustryPeer Comparison as of 07/01/2022

 

Geron Corp ( NASDAQ )

Price: $1.67
Change: +0.12 (7.74%)
Volume: 3.6 M
4:00PM ET 7/01/2022
 
 

Sangamo Therapeutics Inc ( NASDAQ )

Price: $4.28
Change: +0.14 (3.38%)
Volume: 1.3 M
4:00PM ET 7/01/2022
 
 

Organogenesis Holdings Inc ( NASDAQ )

Price: $5.00
Change: +0.12 (2.46%)
Volume: 813.9 K
4:00PM ET 7/01/2022
 
 

NanoString Technologies Inc ( NASDAQ )

Price: $13.15
Change: +0.45 (3.54%)
Volume: 668.6 K
4:00PM ET 7/01/2022
 
 

Coherus BioSciences Inc ( NASDAQ )

Price: $7.83
Change: +0.59 (8.15%)
Volume: 826.6 K
4:00PM ET 7/01/2022
 

Read more news Recent News

Geron Secures Additional $50 Million in Loan Capacity Through End of 2024
4:39PM ET 6/30/2022 MT Newswires

Geron (GERN) late Thursday said lenders Hercules Capital (HTGC) and Silicon Valley Bank have agreed to a $50 million increase to the biopharmaceutical...

Geron Names Faye Feller Chief Medical Officer
4:28PM ET 6/15/2022 MT Newswires

Geron (GERN) said late Wednesday it named Faye Feller chief medical officer, effective July 9. Feller succeeds Aleksandra Rizo, who will transition to the...

--Needham Trims Geron's Price Target to $2 From $3, Buy Rating Kept
11:14AM ET 5/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Geron Completes Stock, Warrant Sale
4:51PM ET 4/01/2022 MT Newswires

Geron (GERN) late Friday said it has closed a public offering of common shares and warrants. The offering covered 53.3 million shares and pre-funded...

Company Profile

Business DescriptionGeron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA. View company web site for more details
Address919 East Hillsdale Boulevard
Foster City, California 94404
Phone+1.650.473.7700
Number of Employees17
Recent SEC Filing07/01/20224
Chairman, President & Chief Executive OfficerJohn A. Scarlett
Chief Operating Officer & Executive Vice PresidentAndrew J. Grethlein
Chief Financial Officer, Treasurer & Executive VPOlivia K. Bloom
Vice President-Clinical DevelopmentFaye Feller

Company Highlights

Price Open$1.55
Previous Close$1.55
52 Week Range$0.99 - 1.74
Market Capitalization$630.3 M
Shares Outstanding377.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/15/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.36
Beta vs. S&P 500N/A
Revenue$1.1 M
Net Profit Margin-8,584.92%
Return on Equity-85.84%

Analyst Ratings as of 06/30/2022

Buy
3
Overweight
1
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset